ARCHIVES

FDA Ceases Exclusion Of Women From Early Drug Studies

This article is from The Cancer Letter archive.

Vol. 19 No. 19 | May 7, 1993

Download PDF Visit The Full Archive

Related Articles

Obey Says NCI “Must Do Better,” Response Dispute GAO Conclusion

August 8, 1980

Advocacy Groups Form Council To Lobby For Cancer Programs To Benefit Minorities

April 28, 1995

GPC Biotech’s Satraplatin Fails To Extend Survival In Hormone-Refractory Prostate Cancer.

November 2, 2007

Upton May Leave NCI Soon, Newell Accepts Post At M.D. Anderson to Head Cancer Prevention

August 17, 1979

NIH To Replace RAC With New Committee

July 19, 1996

Duke Deans Acknowledge Withholding Key Document From Outside Reviewers

January 14, 2011